Subhra Pharma Priavate Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-10-2024
- Paid Up Capital ₹ 5.00 M
as on 24-10-2024
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.13 Cr
as on 24-10-2024
- Satisfied Charges ₹ 2.90 Cr
as on 24-10-2024
- Revenue -8.99%
(FY 2023)
- Profit 11.20%
(FY 2023)
- Ebitda 18.67%
(FY 2023)
- Net Worth 9.96%
(FY 2023)
- Total Assets -19.68%
(FY 2023)
About Subhra Pharma Priavate
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹8.13 Cr. The company has closed loans amounting to ₹2.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manhar Lilaramani and Rohini Lilaramani serve as directors at the Company.
- CIN/LLPIN
U24100MH2010PTC206746
- Company No.
206746
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Aug 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Subhra Pharma Priavate Limited offer?
Subhra Pharma Priavate Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Common Disease Medicines, Anaemia Medicine, Anti Cancer Injection, Anti Infective Drugs & Medicines, Antifungal Injection, Tablet & Syrup, Digestive System Drugs & Medicines, Antiemetic, Sunitinib Malate Capsules.
Who are the key members and board of directors at Subhra Pharma Priavate?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manhar Lilaramani  | Director | 19-Aug-2010 | Current |
| Rohini Lilaramani | Director | 19-Aug-2010 | Current |
Financial Performance of Subhra Pharma Priavate.
Subhra Pharma Priavate Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.99% decrease. The company also saw a substantial improvement in profitability, with a 11.2% increase in profit. The company's net worth moved up by a moderate rise of 9.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Subhra Pharma Priavate?
In 2023, Subhra Pharma Priavate had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 28 Mar 2023 | ₹4.47 Cr | Open |
Others Creation Date: 18 Jul 2020 | ₹4.40 M | Open |
Others Creation Date: 21 May 2018 | ₹2.20 M | Open |
How Many Employees Work at Subhra Pharma Priavate?
Unlock and access historical data on people associated with Subhra Pharma Priavate, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Subhra Pharma Priavate, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Subhra Pharma Priavate's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
